Laudicella, R.; Comelli, A.; Liberini, V.; Vento, A.; Stefano, A.; Spataro, A.; Crocè, L.; Baldari, S.; Bambaci, M.; Deandreis, D.;
et al. [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept. Cancers 2022, 14, 984.
https://doi.org/10.3390/cancers14040984
AMA Style
Laudicella R, Comelli A, Liberini V, Vento A, Stefano A, Spataro A, Crocè L, Baldari S, Bambaci M, Deandreis D,
et al. [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept. Cancers. 2022; 14(4):984.
https://doi.org/10.3390/cancers14040984
Chicago/Turabian Style
Laudicella, Riccardo, Albert Comelli, Virginia Liberini, Antonio Vento, Alessandro Stefano, Alessandro Spataro, Ludovica Crocè, Sara Baldari, Michelangelo Bambaci, Desiree Deandreis,
and et al. 2022. "[68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept" Cancers 14, no. 4: 984.
https://doi.org/10.3390/cancers14040984
APA Style
Laudicella, R., Comelli, A., Liberini, V., Vento, A., Stefano, A., Spataro, A., Crocè, L., Baldari, S., Bambaci, M., Deandreis, D., Arico’, D., Ippolito, M., Gaeta, M., Alongi, P., Minutoli, F., Burger, I. A., & Baldari, S.
(2022). [68Ga]DOTATOC PET/CT Radiomics to Predict the Response in GEP-NETs Undergoing [177Lu]DOTATOC PRRT: The “Theragnomics” Concept. Cancers, 14(4), 984.
https://doi.org/10.3390/cancers14040984